Cargando…

Bioinformatics Method Was Used to Analyze the Highly Expressed Gene FAM83A of Breast Cancer in Young Women

OBJECTIVES: Preliminary analysis of breast cancer related to unknown functional gene FAM83A through bioinformatics knowledge to inform further experimental studies. Select high expression genes for breast cancer and use bioinformatics methods to predict the biological function of FAM83A. METHODS: Ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yongzhe, Wang, Hao, He, Qi, Chen, Yuanyuan, Wang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983250/ https://www.ncbi.nlm.nih.gov/pubmed/35392358 http://dx.doi.org/10.1155/2022/5358030

Ejemplares similares

HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
por: Bartel, Courtney A., et al.
Publicado: (2017)

FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

The Enamel Phenotype in Homozygous Fam83h Truncation Mice
por: Wang, Shih‐Kai, et al.
Publicado: (2019)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019)

Evolutionary analysis of FAM83H in vertebrates
por: Huang, Wushuang, et al.
Publicado: (2017)

Long noncoding antisense RNA FAM83A‐AS1 promotes lung cancer cell progression by increasing FAM83A
por: Shi, Rongxing, et al.
Publicado: (2019)

FAM83A is a potential biomarker for breast cancer initiation
por: Marino, Natascia, et al.
Publicado: (2022)

Systematic Analysis of Gene Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma with a Case Study of FAM83A and FAM83B
por: Cai, Ling, et al.
Publicado: (2019)

LncRNA FAM83A‐AS1 promotes lung adenocarcinoma progression by enhancing the pre‐mRNA stability of FAM83A
por: Wang, Wenyi, et al.
Publicado: (2021)

Novel FAM83H mutations in patients with amelogenesis imperfecta
por: Xin, Wang, et al.
Publicado: (2017)

Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification
por: Lin, Shaochong, et al.
Publicado: (2021)

Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2015)

FAM83G Is a Novel Inducer of Apoptosis
por: Okada, Junichi, et al.
Publicado: (2020)

Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A
por: He, Jinyu, et al.
Publicado: (2019)

Immune implication of FAM83D gene in hepatocellular carcinoma
por: Meng, Tao, et al.
Publicado: (2021)

Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer
por: Jin, Yi, et al.
Publicado: (2022)

A novel FAM83H variant causes familial amelogenesis imperfecta with incomplete penetrance
por: Bai, Rui‐Qi, et al.
Publicado: (2022)

Fam83h null mice support a neomorphic mechanism for human ADHCAI
por: Wang, Shih‐Kai, et al.
Publicado: (2015)

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma
por: Liu, Xin, et al.
Publicado: (2022)

FAM83A antisense RNA 1 (FAM83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPKɑ signaling in lung adenocarcinoma
por: Zhao, Huijie, et al.
Publicado: (2022)

Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer
por: Zhai, Xiuming, et al.
Publicado: (2020)

LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation
por: Zhou, Min, et al.
Publicado: (2022)

FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas
por: Kim, Kyoung Min, et al.
Publicado: (2019)

FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC
por: Kim, Kyoung Min, et al.
Publicado: (2017)

FAM83B is involved in thyroid cancer cell differentiation and migration
por: Cirello, Valentina, et al.
Publicado: (2022)

The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis
por: Yang, Qin, et al.
Publicado: (2020)

FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2021)

FAM83H‐AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma
por: Wang, Siwei, et al.
Publicado: (2021)

Prognostic significance of FAM83D gene expression across human cancer types
por: Walian, Peter J., et al.
Publicado: (2015)

Pan-cancer analysis of the FAM83 family and its association with prognosis and tumor microenvironment
por: Yuan, Shangkun, et al.
Publicado: (2022)

Missense Mutation in Fam83H Gene in Iranian Patients with Amelogenesis Imperfecta
por: POURHASHEMI, S Jalal, et al.
Publicado: (2014)

Casein kinase 1 is recruited to nuclear speckles by FAM83H and SON
por: Kuga, Takahisa, et al.
Publicado: (2016)

Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review
por: Jiang, Yi, et al.
Publicado: (2023)

Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma
por: Zhang, Jing-Tao, et al.
Publicado: (2019)

Correction to: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2021)

Correction: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2023)

FAM83 family oncogenes are broadly involved in human cancers: an integrative multi‐omics approach
por: Snijders, Antoine M., et al.
Publicado: (2017)

Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer
por: Yang, Fan, et al.
Publicado: (2016)

Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma
por: Ahn, Sung Woo, et al.
Publicado: (2020)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
por: Liu, Cuiping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9jd7pq4gs7k18r114vuvacuc9j